GC Cell Balance Sheet Health
Financial Health criteria checks 2/6
GC Cell has a total shareholder equity of ₩541.5B and total debt of ₩49.6B, which brings its debt-to-equity ratio to 9.2%. Its total assets and total liabilities are ₩665.2B and ₩123.7B respectively. GC Cell's EBIT is ₩4.1B making its interest coverage ratio 1.6. It has cash and short-term investments of ₩12.6B.
Key information
9.2%
Debt to equity ratio
₩49.61b
Debt
| Interest coverage ratio | 1.6x |
| Cash | ₩12.56b |
| Equity | ₩541.48b |
| Total liabilities | ₩123.69b |
| Total assets | ₩665.17b |
Recent financial health updates
Recent updates
We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative
Mar 19
We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt
Feb 22Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?
Jan 18
Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?
Dec 14Financial Position Analysis
Short Term Liabilities: A144510's short term assets (₩63.9B) do not cover its short term liabilities (₩76.8B).
Long Term Liabilities: A144510's short term assets (₩63.9B) exceed its long term liabilities (₩46.9B).
Debt to Equity History and Analysis
Debt Level: A144510's net debt to equity ratio (6.8%) is considered satisfactory.
Reducing Debt: A144510's debt to equity ratio has increased from 0% to 9.2% over the past 5 years.
Debt Coverage: A144510's debt is not well covered by operating cash flow (7.4%).
Interest Coverage: A144510's interest payments on its debt are not well covered by EBIT (1.6x coverage).